Increased lung and bladder cancer incidence in adults after in utero and early-life arsenic exposure
- PMID: 24859871
- PMCID: PMC4344186
- DOI: 10.1158/1055-9965.EPI-14-0059
Increased lung and bladder cancer incidence in adults after in utero and early-life arsenic exposure
Abstract
Background: From 1958 to 1970, >100,000 people in northern Chile were exposed to a well-documented, distinct period of high drinking water arsenic concentrations. We previously reported ecological evidence suggesting that early-life exposure in this population resulted in increased mortality in adults from several outcomes, including lung and bladder cancer.
Methods: We have now completed the first study ever assessing incident cancer cases after early-life arsenic exposure, and the first study on this topic with individual participant exposure and confounding factor data. Subjects included 221 lung and 160 bladder cancer cases diagnosed in northern Chile from 2007 to 2010, and 508 age and gender-matched controls.
Results: ORs adjusted for age, sex, and smoking in those only exposed in early life to arsenic water concentrations of ≤110, 110 to 800, and >800 μg/L were 1.00, 1.88 [95% confidence interval (CI), 0.96-3.71], and 5.24 (3.05-9.00; P(trend) < 0.001) for lung cancer, and 1.00, 2.94 (1.29-6.70), and 8.11 (4.31-15.25; P(trend) < 0.001) for bladder cancer. ORs were lower in those not exposed until adulthood. The highest category (>800 μg/L) involved exposures that started 49 to 52 years before, and ended 37 to 40 years before the cancer cases were diagnosed.
Conclusion: Lung and bladder cancer incidence in adults was markedly increased following exposure to arsenic in early life, even up to 40 years after high exposures ceased. Such findings have not been identified before for any environmental exposure, and suggest that humans are extraordinarily susceptible to early-life arsenic exposure.
Impact: Policies aimed at reducing early-life exposure may help reduce the long-term risks of arsenic-related disease.
©2014 American Association for Cancer Research.
Conflict of interest statement
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4344186/bin/nihms599327f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4344186/bin/nihms599327f2.gif)
Similar articles
-
Drinking water arsenic in northern chile: high cancer risks 40 years after exposure cessation.Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):623-30. doi: 10.1158/1055-9965.EPI-12-1190. Epub 2013 Jan 25. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23355602 Free PMC article.
-
Lung, Bladder, and Kidney Cancer Mortality 40 Years After Arsenic Exposure Reduction.J Natl Cancer Inst. 2018 Mar 1;110(3):241-249. doi: 10.1093/jnci/djx201. J Natl Cancer Inst. 2018. PMID: 29069505 Free PMC article.
-
Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water.Am J Epidemiol. 1998 Apr 1;147(7):660-9. doi: 10.1093/oxfordjournals.aje.a009507. Am J Epidemiol. 1998. PMID: 9554605
-
Magnitude of arsenic toxicity in tube-well drinking water in Bangladesh and its adverse effects on human health including cancer: evidence from a review of the literature.Asian Pac J Cancer Prev. 2003 Jan-Mar;4(1):7-14. Asian Pac J Cancer Prev. 2003. PMID: 12718695 Review.
-
Arsenic exposure and its impact on health in Chile.J Health Popul Nutr. 2006 Jun;24(2):164-75. J Health Popul Nutr. 2006. PMID: 17195557 Review.
Cited by
-
Can the use of antithrombotic drugs be a predictive factor in the early diagnosis of bladder cancer?: A single-center analysis.Medicine (Baltimore). 2024 May 17;103(20):e38228. doi: 10.1097/MD.0000000000038228. Medicine (Baltimore). 2024. PMID: 38758868 Free PMC article.
-
An overview of the Be Well Home Health Navigator Program to reduce contaminants in well water: Design and methods.Contemp Clin Trials. 2024 May;140:107497. doi: 10.1016/j.cct.2024.107497. Epub 2024 Mar 11. Contemp Clin Trials. 2024. PMID: 38471641 Clinical Trial.
-
Update of the risk assessment of inorganic arsenic in food.EFSA J. 2024 Jan 18;22(1):e8488. doi: 10.2903/j.efsa.2024.8488. eCollection 2024 Jan. EFSA J. 2024. PMID: 38239496 Free PMC article.
-
Vaping, Environmental Toxicants Exposure, and Lung Cancer Risk.Cancers (Basel). 2023 Sep 12;15(18):4525. doi: 10.3390/cancers15184525. Cancers (Basel). 2023. PMID: 37760496 Free PMC article. Review.
-
Changes in spatial clusters of cancer incidence and mortality over 15 years in South Korea: Implication to cancer control.Cancer Med. 2023 Aug;12(16):17418-17427. doi: 10.1002/cam4.6365. Epub 2023 Jul 25. Cancer Med. 2023. PMID: 37489117 Free PMC article.
References
-
- Miller MD, Marty AM, Arcus A, Brown J, Morry D, Sandy S. Differences between children and adults: implications in risk assessment at California EPA. Int J Toxicol. 2001;21:403–18. - PubMed
-
- U.S. Environmental Protection Agency. Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens. Washington DC: 2005.
-
- Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971;284:878–81. - PubMed
-
- Nilsson R. Environmental tobacco smoke revisited: the reliability of the data used for risk assessment. Risk Anal. 2001;21:737–60. - PubMed
-
- Preston DL, Cullings H, Suyama A, Funamoto S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst. 2008;100:428–36. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical